Patent details

Basic Information

Publication number:

EP3174995

PCT Application Number:

EP2015067098

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157422502

PCT Publication Number:

WO2016016157

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT

French Title of Invention:

MARQUEURS GÉNÉTIQUES POUR LA PRÉDICTION DE LA RÉACTIVITÉ À UNE THÉRAPIE AVEC UN AGENT D'AUGMENTATION DE HDL OU D'IMITATION DE HDL

German Title of Invention:

GENETISCHE MARKER ZUR VORHERSAGE DES ANSPRECHENS AUF EINE THERAPIE MIT HDL-ERHÖHUNGS- ODER HDL-NACHAHMUNGSMITTEL

SPC Number:

Dates

Filing date:

27/07/2015

Grant date:

19/08/2020

EP Publication Date:

07/06/2017

PCT Publication Date:

04/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/08/2020

EP B1 Publication Date:

19/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/07/2021

Expiration date:

27/07/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/08/2020

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

DUBÉ, Marie-Pierre

Address:

Canada (CA)

2

Name:

TARDIF, Jean-Claude

Address:

Canada (CA)

Priority

Priority Number:

14179048

Priority Date:

30/07/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C12Q 1/6883;

Publication

European Patent Bulletin

Issue number:

202034

Publication date:

19/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages